Particle.news

Download on the App Store

UK Advisers Expected to Reject Targeted Prostate Screening as Sunak Urges Action

Caution stems from doubts over PSA test accuracy that raise risks of overdiagnosis.

Overview

  • Media reports indicate the UK National Screening Committee is likely to advise against a national targeted programme, though no decision has been published.
  • The committee is due to meet next month to make formal recommendations, following briefings that questioned cost-effectiveness.
  • Rishi Sunak made a rare public intervention urging ministers not to shelve plans, arguing a targeted approach would save lives.
  • Prostate Cancer UK warned it would be deeply disappointed by a rejection and highlighted its £42 million Transform trial, which it says could produce new evidence within about two years.
  • The charity is pressing for updated NHS guidance so GPs can proactively offer PSA tests to higher-risk men, as prostate cancer remains the UK’s most common cancer with tens of thousands of new cases annually.